SPC423
Sacitúsúmab govitecan
Status:
UmsóknApplication date:
15.2.2023Application published:
15.3.2023
Max expiry date:
1.12.2034Medicine name:
TrodelvyMedicine for children:
No
Timeline
Today
15.2.2023Application
15.3.2023Publication
1.12.2034Expires
Marketing license
IS authorization number:
EU/1/21/1592Date:
7.12.2021
Foreign authorization number:
EU/1/21/1592Date:
22.11.2022
Owner
Name:
Immunomedics, Inc.Address:
c/o Gilead Sciences, Inc., 333 Lakeside Drive, Foster City, CA 94404 US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP3912643